Clinical value of CD133 and nestin in patients with glioma: a population-based study.
about
Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysisAPNG as a prognostic marker in patients with glioblastoma.Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cellsGlioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.Glioma Cells in the Tumor Periphery Have a Stem Cell PhenotypeExpression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.Recent advances and future of immunotherapy for glioblastoma.NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma.Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradationER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation.Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.Linking invasive motility to protein expression in single tumor cells.Novel Cancer Stem Marker and Its Applicability for Grading Primary Human Gliomas.Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival
P2860
Q26865791-F2DA46ED-0F47-4296-8CB6-FD4F44127B59Q33852894-90E56071-023E-4DC1-BC4D-D2BCA9851AC9Q35986799-7B6007ED-020F-45FF-847D-A448F895F93DQ35988225-F1D9461B-062E-4B13-A9C7-C2E58CD95D13Q36015831-D066BF97-92FF-43EF-9DDC-85F6EACD37CBQ36234890-5C2565BE-2CB4-4CED-82E1-01D1D8D9088CQ37239071-5A711E73-D0B5-4A94-AB1D-DBD7CC158C6EQ37520199-1EBDEEAA-2587-4540-99F6-0072DA6CE431Q37679063-9CC4FCE4-FBA4-4001-A341-6B0539019B40Q38712677-24959F03-941E-408F-A505-FE571576BE08Q38815443-BF8254FF-F265-46A2-9387-F82BB804E850Q41512201-A905A484-91F7-4EE2-942C-9CF6A176AF72Q42725487-64C63D28-4066-4785-B9EC-E73EF11E7B61Q47201757-66B74588-F77F-4D3B-9A25-81EF296CC329Q47836853-1927550D-64A9-4278-827C-0EC6FC837DBBQ50055177-9A3002C1-6BD0-4E9A-A24F-889CCC84F47CQ51746838-D77B6CCE-D32A-4AD1-9806-3EAE418D477AQ55259357-0738C6E5-C428-401C-BB6C-E21530B2FAECQ57296293-71BD3891-55D2-4811-B378-4FBDAD362932
P2860
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@ast
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@en
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@nl
type
label
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@ast
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@en
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@nl
prefLabel
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@ast
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@en
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@nl
P2860
P50
P1476
Clinical value of CD133 and nestin in patients with glioma: a population-based study.
@en
P2093
Bjarne W Kristensen
Stine S Jensen
P2860
P304
P577
2014-06-15T00:00:00Z